China scales biotech, Korea carves a niche

China’s biopharmaceutical rise is no longer incremental — it is structural, accelerated and globally consequential. So formidable has China’s biotech sector become that the US National Security Commission on Emerging Biotechnology recently warned policymakers they have a three-year window to act decisively if the US hopes to retain global leadership. For South Korea, which has designated biotechnology as one of three “game changers” for scientific sovereignty, the message is sobering. The gap wi

By The Korea Herald